NVCR compared with SYK: revenue, margins and what each company keeps, and the suppliers and customers both name

NVCRNovoCure Ltd

Mkt capRevenueRevenue

SYKStryker Corp

Mkt capRevenueRevenue

Compare

NVCRNovoCure Ltd

SYKStryker Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

NVCR: latest quarter is a loss; flow not drawable.Method ›

Price

rebased to 0%

NVCR, solidSYK, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NVCR 3

ZLABZai Labcustomer

—Zai Lab (Shanghai)unlistedcustomer

—Zaiunlistedcustomer

Shared 0

No shared counterparties.

Only SYK 1

UFPTUFP Technologiessupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

NVCRNovoCure Ltd

13.29▼−1.90%

Mkt cap$1.6BRevenue$193MQ3 FY26Revenue$655MFY25

SYKStryker Corp

327.19▼−2.35%

Regular sessionNov 6 '26

Mkt cap$127.6BRevenue$6.5BQ3 FY26Revenue$25.1BFY25

Compare

Regular sessionNov 6 '26

NVCRNovoCure Ltd

SYKStryker Corp

13.29▼−1.90%

Price

327.19▼−2.35%

$1.6B

Mkt cap

$127.6B

Q3 FY26$193M

Revenue

$6.5BQ3 FY26

FY25$655M

Revenue

$25.1BFY25

NVCR13.29▼−1.90%vsSYK327.19▼−2.35%Regular sessionNov 6 '26